{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cirrhosis", "curcumin", "ginseng", "medicinal plants", "silymarin", "systematic review"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37218361", "DateCompleted": {"Year": "2023", "Month": "07", "Day": "05"}, "DateRevised": {"Year": "2023", "Month": "07", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "05", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.7816"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "37", "Issue": "7", "PubDate": {"Year": "2023", "Month": "Jul"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "The effect of medicinal plants on cirrhosis: A systematic review of clinical trials.", "Pagination": {"StartPage": "3083", "EndPage": "3096", "MedlinePgn": "3083-3096"}, "Abstract": {"AbstractText": ["Medicinal plants with minimal side effects, low cost, and liver-protective effects can be a suitable treatment option for cirrhosis. Therefore, this systematic review aimed to determine the effectiveness of herbal medicines on cirrhosis, a life-threatening liver disease. PubMed, Scopus, Web of Science, and Google Scholar were systematically searched for clinical trials that investigated the effect of medicinal plants on cirrhosis. This review includes 11 clinical trials, of which eight studies including 613 patients assessed the effect of silymarin on cirrhosis. Three of six studies showed the beneficial effects of silymarin on aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Two studies including 118 patients investigated the effect of curcumin on cirrhosis, one showing improvement in quality of life and the other showing improvements in alkaline phosphatase (ALP), bilirubin, prothrombin time (PT), and the international normalized ratio (INR). An article including four patients investigated the effect of ginseng on cirrhosis; two patients reported improvement in the Child-Pugh score, and ascites decreased in two. All studies included here reported no or negligible side effects. Results showed that medicinal plants including silymarin, curcumin, and ginseng have beneficial effects on cirrhosis. However, due to the limited number of studies, further high-quality studies are warranted."], "CopyrightInformation": "\u00a9 2023 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran."}], "LastName": "Amini", "ForeName": "Sepide", "Initials": "S"}, {"Identifier": ["0000-0002-5861-6129"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran."}, {"Identifier": [], "Affiliation": "Anesthesia and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran."}], "LastName": "Bagherniya", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": ["0000-0002-5762-3917"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Department, Royal College of Surgeons in Ireland Bahrain, Adliya, Bahrain."}], "LastName": "Butler", "ForeName": "Alexandra E", "Initials": "AE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran."}, {"Identifier": [], "Affiliation": "Anesthesia and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran."}], "LastName": "Askari", "ForeName": "Gholamreza", "Initials": "G"}, {"Identifier": ["0000-0002-8656-1444"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Sahebkar", "ForeName": "Amirhossein", "Initials": "A"}], "PublicationTypeList": ["Systematic Review", "Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}, {"RegistryNumber": "0", "NameOfSubstance": "Silymarin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Liver Cirrhosis"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Silymarin"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abarikwu, S. O., Durojaiye, M., Alabi, A., Asonye, B., & Akiri, O. (2016). Curcumin protects against gallic acid-induced oxidative stress, suppression of glutathione antioxidant defenses, hepatic and renal damage in rats. Renal Failure, 38(2), 321-329."}, {"Citation": "Abenavoli, L., Izzo, A. A., Mili\u0107, N., Cicala, C., Santini, A., & Capasso, R. (2018). Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytotherapy Research, 32(11), 2202-2213."}, {"Citation": "Ali, M., Khan, T., Fatima, K., Ali, Q. A., Ovais, M., Khalil, A. T., Ullah, I., Raza, A., Shinwari, Z. K., & Idrees, M. (2018). Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions. Phytotherapy Research, 32(2), 199-215."}, {"Citation": "Alvari, A., Ahmad, F. J., & Abdin, M. (2012). Contemporary overview on clinical trials and future prospects of hepato-protective herbal medicines. Reviews on Recent Clinical Trials, 7(3), 214-223."}, {"Citation": "Angulo, P., Patel, T., Jorgensen, R. A., Therneau, T. M., & Lindor, K. D. (2000). Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology, 32(5), 897-900."}, {"Citation": "Aziz, M., Saeed, F., Ahmad, N., Ahmad, A., Afzaal, M., Hussain, S., Mohamed, A. A., Alamri, M. S., & Anjum, F. M. (2021). Biochemical profile of milk thistle (Silybum marianum L.) with special reference to silymarin content. Food Science & Nutrition, 9(1), 244-250."}, {"Citation": "Bagherniya, M., Khedmatgozar, H., Fakheran, O., Xu, S., Johnston, T. P., & Sahebkar, A. (2021). Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome. Phytotherapy Research, 35(9), 4804-4833."}, {"Citation": "Bagherniya, M., Nobili, V., Blesso, C. N., & Sahebkar, A. (2018). Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. Pharmacological Research, 130, 213-240."}, {"Citation": "Cacciapuoti, F., Scognamiglio, A., Palumbo, R., Forte, R., & Cacciapuoti, F. (2013). Silymarin in non alcoholic fatty liver disease. World Journal of Hepatology, 5(3), 109."}, {"Citation": "Chaudhary, G. D., Kamboj, P., Singh, I., & Kalia, A. N. (2010). Herbs as liver savers-a review. Indian Journal of Natural Products and Resources, 1, 397-408."}, {"Citation": "Chen, I. S., Chen, Y. C., Chou, C. H., Chuang, R. F., Sheen, L. Y., & Chiu, C. H. (2012). Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis. Journal of the Science of Food and Agriculture, 92(7), 1441-1447."}, {"Citation": "Colica, C., Boccuto, L., & Abenavoli, L. (2017). Silymarin: An option to treat non-alcoholic fatty liver disease. World Journal of Gastroenterology, 23(47), 8437-8438."}, {"Citation": "Dadkhah Tehrani, S., Shojaei, M., Bagherniya, M., Pirro, M., & Sahebkar, A. (2023). The effects of phytochemicals on serum triglycerides in subjects with hypertriglyceridemia: A systematic review of randomized controlled trials. Phytotherapy Research, 37(4), 1640-1662. https://doi.org/10.1002/ptr.7763"}, {"Citation": "Dehghani, S. M., Imanieh, M. H., Haghighat, M., Malekpour, A., & Falizkar, Z. (2013). Etiology and complications of liver cirrhosis in children: Report of a single center from southern Iran. Middle East Journal of Digestive Diseases, 5(1), 41-46."}, {"Citation": "Del Prete, A., Scalera, A., Iadevaia, M. D., Miranda, A., Zulli, C., Gaeta, L., Tuccillo, C., Federico, A., & Loguercio, C. (2012). Herbal products: Benefits, limits, and applications in chronic liver disease. Evidence-Based Complementary and Alternative Medicine, 2012, 837939. https://doi.org/10.1155/2012/837939"}, {"Citation": "Dhiman, A., Nanda, A., & Ahmad, S. (2012). A recent update in research on the antihepatotoxic potential of medicinal plants. Zhong Xi Yi Jie He Xue Bao=Journal of Chinese Integrative Medicine, 10(2), 117-127."}, {"Citation": "Duval, F., Moreno-Cuevas, J. E., Gonz\u00e1lez-Garza, M. T., Maldonado-Bernal, C., & Cruz-Vega, D. E. (2015). Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response. International Journal of Inflammation, 2015, 943497. https://doi.org/10.1155/2015/943497"}, {"Citation": "Ebadi, M., Bhanji, R. A., Mazurak, V. C., & Montano-Loza, A. J. (2019). Sarcopenia in cirrhosis: From pathogenesis to interventions. Journal of Gastroenterology, 54(10), 845-859."}, {"Citation": "Enayati, A., Banach, M., Jamialahmadi, T., & Sahebkar, A. (2022). Protective role of nutraceuticals against myocarditis. Biomedicine and Pharmacotherapy, 146, 112242."}, {"Citation": "Fallah Huseini, H., Alavian, S., Toliat, T., Jamshidi, A., Heshmat, R., Naghdi Badi, H., & Khani, M. (2005). The efficacy of herbal medicine Khar Maryam (Silybum marianum (L.) Gaertn.) on liver cirrhosis in chronic hepatitis B patients. Journal of Medicinal Plants, 4(13), 1-6."}, {"Citation": "Famouri, F., Salehi, M.-M., Rostampour, N., Hashemi, E., & Shahsanaee, A. (2016). The effect of silymarin on non-alcoholic fatty liver disease of children. Journal of Herbmed Pharmacology, 6(1), 16-20."}, {"Citation": "Fan, J., Wang, Y., You, Y., Ai, Z., Dai, W., Piao, C., Liu, J., & Wang, Y. (2019). Fermented ginseng improved alcohol liver injury in association with changes in the gut microbiota of mice. Food & Function, 10(9), 5566-5573."}, {"Citation": "Farzaei, M. H., Zobeiri, M., Parvizi, F., El-Senduny, F. F., Marmouzi, I., Coy-Barrera, E., Naseri, R., Nabavi, S. M., Rahimi, R., & Abdollahi, M. (2018). Curcumin in liver diseases: A systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients, 10(7), 855."}, {"Citation": "Fathalah, W. F., Abdel Aziz, M. A., Abou el Soud, N. H., & El Raziky, M. E. S. (2017). High dose of silymarin in patients with decompensated liver disease: A randomized controlled trial. Journal of Interferon & Cytokine Research, 37(11), 480-487."}, {"Citation": "Feh\u00e9r, J., & Lengyel, G. (2012). Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Current Pharmaceutical Biotechnology, 13(1), 210-217."}, {"Citation": "Feng, D., Zou, J., Su, D., Mai, H., Zhang, S., Li, P., & Zheng, X. (2019). Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE\u2212/\u2212 mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-\u03baB inflammation. Nutrition & Metabolism, 16(1), 1-11."}, {"Citation": "Ferenci, P., Dragosics, B., Dittrich, H., Frank, H., Benda, L., Lochs, H., Meryn, S., Base, W., & Schneider, B. (1989). Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. Journal of Hepatology, 9(1), 105-113."}, {"Citation": "Fern\u00e1ndez-L\u00e1zaro, D., Mielgo-Ayuso, J., Seco Calvo, J., C\u00f3rdova Mart\u00ednez, A., Caballero Garc\u00eda, A., & Fernandez-Lazaro, C. I. (2020). Modulation of exercise-induced muscle damage, inflammation, and oxidative markers by curcumin supplementation in a physically active population: A systematic review. Nutrients, 12(2), 501."}, {"Citation": "Flora, K., Hahn, M., Rosen, H., & Benner, K. (1998). Milk thistle (Silybum marianum) for the therapy of liver disease. The American Journal of Gastroenterology, 93(2), 139-143."}, {"Citation": "Ganji, A., Farahani, I., Saeedifar, A. M., Mosayebi, G., Ghazavi, A., Majeed, M., Jamialahmadi, T., & Sahebkar, A. (2021). Protective effects of curcumin against lipopolysaccharide-induced toxicity. Current Medicinal Chemistry, 28(33), 69157-6930. https://doi.org/10.2174/092986732866621052512470"}, {"Citation": "Ge, P. S., & Runyon, B. A. (2016). Treatment of patients with cirrhosis. New England Journal of Medicine, 375(8), 767-777."}, {"Citation": "George, P. (2011). Concerns regarding the safety and toxicity of medicinal plants-an overview. Journal of Applied Pharmaceutical Science, 1(6), 40-44."}, {"Citation": "Ghavami, A., Ziaei, R., Foshati, S., Kermani, M. A. H., Zare, M., & Amani, R. (2020). Benefits and harms of ginseng supplementation on liver function? A systematic review and meta-analysis. Complementary Therapies in Clinical Practice, 39, 101173."}, {"Citation": "Gillessen, A., & Schmidt, H. H. J. (2020). Silymarin as supportive treatment in liver diseases: A narrative review. Advances in Therapy, 37(4), 1279-1301."}, {"Citation": "Govind, P. (2011). Medicinal plants against liver diseases. IJPR, 2(5), 115-121."}, {"Citation": "Guan, Y.-S., & He, Q. (2015). Plants consumption and liver health. Evidence-Based Complementary and Alternative Medicine, 2015, 824185. https://doi.org/10.1155/2015/824185"}, {"Citation": "Guo, M., Shao, S., Wang, D., Zhao, D., & Wang, M. (2021). Recent progress in polysaccharides from Panax ginseng CA Meyer. Food & Function, 12(2), 494-518."}, {"Citation": "Halegoua-De Marzio, D., Kraft, W. K., Daskalakis, C., Ying, X., Hawke, R. L., & Navarro, V. J. (2012). Limited sampling estimates of epigallocatechin gallate exposures in cirrhotic and noncirrhotic patients with hepatitis C after single oral doses of green tea extract. Clinical Therapeutics, 34(12), 2279-2285 e2271."}, {"Citation": "Hassanizadeh, S., Shojaei, M., Bagherniya, M., Orekhov, A. N., & Sahebkar, A. (2023). Effect of nano-curcumin on various diseases: A comprehensive review of clinical trials. BioFactors. https://doi.org/10.1002/biof.1932"}, {"Citation": "Hassanzadeh, S., Read, M. I., Bland, A. R., Majeed, M., Jamialahmadi, T., & Sahebkar, A. (2020). Curcumin: An inflammasome silencer. Pharmacological Research, 159, 104921."}, {"Citation": "Heidari, H., Bagherniya, M., Majeed, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2023). Curcumin-piperine co-supplementation and human health: A comprehensive review of preclinical and clinical studies. Phytotherapy Research, 37(4), 1462-1487. https://doi.org/10.1002/ptr.7737"}, {"Citation": "Hewlings, S. J., & Kalman, D. S. (2017). Curcumin: A review of its effects on human health. Food, 6(10), 92."}, {"Citation": "Higgins, J. P., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., & Welch, V. A. (2019). Cochrane handbook for systematic reviews of interventions. John Wiley & Sons."}, {"Citation": "Hosseini, A., Penson, P. E., Cicero, A. F. G., Golledge, J., Al-Rasadi, K., Jamialahmadi, T., & Sahebkar, A. (2021). Potential benefits of phytochemicals for abdominal aortic aneurysm. Current Medicinal Chemistry, 28(41), 8595-8607."}, {"Citation": "Hosseini, S. A., Zahedipour, F., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021). Pulmonary fibrosis: Therapeutic and mechanistic insights into the role of phytochemicals. BioFactors, 47(3), 250-269."}, {"Citation": "Hsu, Y.-J., Wang, C.-Y., Lee, M.-C., & Huang, C.-C. (2020). Hepatoprotection by traditional essence of ginseng against carbon tetrachloride-Induced liver damage. Nutrients, 12(10), 3214."}, {"Citation": "H\u00fcttl, M., Markova, I., Miklankova, D., Zapletalova, I., Poruba, M., Racova, Z., Vecera, R., & Malinska, H. (2021). The beneficial additive effect of silymarin in metformin therapy of liver steatosis in a pre-diabetic model. Pharmaceutics, 14(1), 45."}, {"Citation": "Iranshahi, M., Sahebkar, A., Takasaki, M., Konoshima, T., & Tokuda, H. (2009). Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo. European Journal of Cancer Prevention, 18(5), 412-415."}, {"Citation": "Jaeschke, H. (2011). Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts. Journal of Gastroenterology and Hepatology, 26, 173-179."}, {"Citation": "Jalali, M., Mahmoodi, M., Mosallanezhad, Z., Jalali, R., Imanieh, M. H., & Moosavian, S. P. (2020). The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine, 48, 102283."}, {"Citation": "Jazayeri-Tehrani, S. A., Rezayat, S. M., Mansouri, S., Qorbani, M., Alavian, S. M., Daneshi-Maskooni, M., & Hosseinzadeh-Attar, M. J. (2019). Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): A double-blind randomized placebo-controlled clinical trial. Nutrition & Metabolism, 16(1), 1-13."}, {"Citation": "Jo, Y. H., Lee, H., Oh, M. H., Lee, G. H., Lee, Y. J., Lee, J. S., Kim, M. J., Kim, W. Y., Kim, J. S., Yoo, D. S., Cho, S. W., Cha, S. W., & Pyo, M. K. (2020). Antioxidant and hepatoprotective effects of Korean ginseng extract GS-KG9 in a D-galactosamine-induced liver damage animal model. Nutrition Research and Practice, 14(4), 334-351."}, {"Citation": "Kalopitas, G., Antza, C., Doundoulakis, I., Siargkas, A., Kouroumalis, E., Germanidis, G., Samara, M., & Chourdakis, M. (2021). Impact of silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis. Nutrition, 83, 111092."}, {"Citation": "Karkanis, A., Bilalis, D., & Efthimiadou, A. (2011). Cultivation of milk thistle (Silybum marianum L. Gaertn.), a medicinal weed. Industrial Crops and Products, 34(1), 825-830."}, {"Citation": "Kheiripour, N., Karimi, J., Khodadadi, I., Tavilani, H., Goodarzi, M. T., & Hashemnia, M. (2019). Hepatoprotective effects of silymarin on liver injury via irisin upregulation and oxidative stress reduction in rats with type 2 diabetes. Iranian Journal of Medical Sciences, 44(2), 108-117."}, {"Citation": "Kiefer, D. S., & Pantuso, T. (2003). Panax ginseng. American Family Physician, 68(8), 1539-1542."}, {"Citation": "Kim, H. H., Kim, S. M., Kim, K. S., Kwak, M. A., Kim, S. G., Kim, B. S., & Lee, C. H. (2016). Combined effect of granulocyte-Colony-stimulating factor-induced bone marrow-derived stem cells and red ginseng in patients with decompensated liver cirrhosis (combined effect of G-CSF and red ginseng in liver cirrhosis). The Journal of Korean Medicine, 37(4), 36-44."}, {"Citation": "Kim, J. H., Yi, Y.-S., Kim, M.-Y., & Cho, J. Y. (2017). Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. Journal of Ginseng Research, 41(4), 435-443."}, {"Citation": "Kim, S. H., Oh, D.-S., Oh, J. Y., Son, T. G., Yuk, D. Y., & Jung, Y.-S. (2016). Silymarin prevents restraint stress-induced acute liver injury by ameliorating oxidative stress and reducing inflammatory response. Molecules, 21(4), 443."}, {"Citation": "Kitts, D. D., & Hu, C. (2000). Efficacy and safety of ginseng. Public Health Nutrition, 3(4a), 473-485."}, {"Citation": "Kumar, C. H., Ramesh, A., Kumar, J. N. S., & Ishaq, B. M. (2011). A review on hepatoprotective activity of medicinal plants. International Journal of Pharmaceutical Sciences and Research, 2(3), 501."}, {"Citation": "Lee, D. C. W., & Lau, A. S. Y. (2011). Effects of Panax ginseng on tumor necrosis factor-\u03b1-mediated inflammation: A mini-review. Molecules, 16(4), 2802-2816."}, {"Citation": "Lee, D. E., Lee, S. J., Kim, S. J., Lee, H.-S., & Kwon, O.-S. (2019). Curcumin ameliorates nonalcoholic fatty liver disease through inhibition of O-GlcNAcylation. Nutrients, 11(11), 2702."}, {"Citation": "Lee, Y.-M., Yoon, H., Park, H.-M., Song, B. C., & Yeum, K.-J. (2017). Implications of red Panax ginseng in oxidative stress associated chronic diseases. Journal of Ginseng Research, 41(2), 113-119."}, {"Citation": "Lemasters, J. J., & Jaeschke, H. (2020). Oxidative stress and inflammation in the liver. In The Liver: Biology and Pathobiology (pp. 714-727). John Wiley & Sons."}, {"Citation": "Lestari, M. L. A. D., & Indrayanto, G. (2014). Curcumin. In profiles of drug substances, excipients and related methodology (Vol. 39, pp. 113-204). Elsevier."}, {"Citation": "Liu, R., Chen, Q.-H., Ren, J.-W., Sun, B., Cai, X.-X., Li, D., Mao, R. X., Wu, X., & Li, Y. (2018). Ginseng (Panax ginseng Meyer) oligopeptides protect against binge drinking-induced liver damage through inhibiting oxidative stress and inflammation in rats. Nutrients, 10(11), 1665."}, {"Citation": "Lucena, M., Andrade, R., De la Cruz, J., Rodriguez-Mendizabal, M., Blanco, E., & de la Cuesta, F. S. (2002). Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. International Journal of Clinical Pharmacology and Therapeutics, 40(1), 2-8."}, {"Citation": "Mahdavi, A., Bagherniya, M., Fakheran, O., Reiner, \u017d., Xu, S., & Sahebkar, A. (2020). Medicinal plants and bioactive natural compounds as inhibitors of HMG-CoA reductase: A literature review. BioFactors, 46(6), 906-926."}, {"Citation": "Mahdavi, A., Bagherniya, M., Mirenayat, M. S., Atkin, S. L., & Sahebkar, A. (2021). Medicinal plants and phytochemicals regulating insulin resistance and glucose homeostasis in type 2 diabetic patients: A clinical review. Advances in Experimental Medicine and Biology, 1308, 161-183."}, {"Citation": "Mahdavi, A., Moradi, S., Askari, G., Iraj, B., Sathyapalan, T., Guest, P. C., Bagherniya, M., & Sahebkar, A. (2021). Effect of curcumin on glycemic control in patients with type 2 diabetes: A systematic review of randomized clinical trials. Advances in Experimental Medicine and Biology, 1291, 139-149."}, {"Citation": "Momtazi-Borojeni, A. A., Haftcheshmeh, S. M., Esmaeili, S. A., Johnston, T. P., Abdollahi, E., & Sahebkar, A. (2018). Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmunity Reviews, 17(2), 125-135."}, {"Citation": "Moon, A. M., Singal, A. G., & Tapper, E. B. (2020). Contemporary epidemiology of chronic liver disease and cirrhosis. Clinical Gastroenterology and Hepatology, 18(12), 2650-2666."}, {"Citation": "Nasri, H. (2013). Toxicity and safety of medicinal plants. Journal of Herbmed Pharmacology, 2(2), 21-22."}, {"Citation": "Ni, X., & Wang, H. (2016). Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD). American Journal of Translational Research, 8(2), 1073."}, {"Citation": "Niu, Y., He, J., Ahmad, H., Shen, M., Zhao, Y., Gan, Z., Zhang, L., Zhong, X., Wang, C., & Wang, T. (2019). Dietary curcumin supplementation increases antioxidant capacity, upregulates Nrf2 and Hmox1 levels in the liver of piglet model with intrauterine growth retardation. Nutrients, 11(12), 2978."}, {"Citation": "Nouri-Vaskeh, M., Afshan, H., Mahdavi, A. M., Alizadeh, L., Fan, X., & Zarei, M. (2020). Curcumin ameliorates health-related quality of life in patients with liver cirrhosis: A randomized, double-blind placebo-controlled trial. Complementary Therapies in Medicine, 49, 102351."}, {"Citation": "Nouri-Vaskeh, M., Malek Mahdavi, A., Afshan, H., Alizadeh, L., & Zarei, M. (2020). Effect of curcumin supplementation on disease severity in patients with liver cirrhosis: A randomized controlled trial. Phytotherapy Research, 34(6), 1446-1454."}, {"Citation": "Olaleye, M. T., & Rocha, B. T. J. (2008). Acetaminophen-induced liver damage in mice: Effects of some medicinal plants on the oxidative defense system. Experimental and Toxicologic Pathology, 59(5), 319-327."}, {"Citation": "Oluyemisi, F., Henry, O., & Peter, O. (2012). Standardization of herbal medicines-a review. International Journal of Biodiversity and Conservation, 4(3), 101-112."}, {"Citation": "Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hr\u00f3bjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., \u2026 Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Systematic Reviews, 10(1), 1-11."}, {"Citation": "Par\u00e9s, A., Planas, R., Torres, M., Caballer\u00eda, J., Viver, J. M., Acero, D., Pan\u00e9s, J., Rigau, J., Santos, J., & Rod\u00e9s, J. (1998). Effects of silymarin in alcoholic patients with cirrhosis of the liver: Results of a controlled, double-blind, randomized and multicenter trial. Journal of Hepatology, 28(4), 615-621."}, {"Citation": "Park, S. K., Hyun, S. H., In, G., Park, C.-K., Kwak, Y.-S., Jang, Y.-J., Kim, B., Kim, J.-H., & Han, C.-K. (2021). The antioxidant activities of Korean red ginseng (Panax ginseng) and ginsenosides: A systemic review through in vivo and clinical trials. Journal of Ginseng Research, 45(1), 41-47."}, {"Citation": "Parsamanesh, N., Moossavi, M., Bahrami, A., Butler, A. E., & Sahebkar, A. (2018). Therapeutic potential of curcumin in diabetic complications. Pharmacological Research, 136, 181-193."}, {"Citation": "Petrovska, B. B. (2012). Historical review of medicinal plants' usage. Pharmacognosy Reviews, 6(11), 1-5."}, {"Citation": "Rafiee, S., Bagherniya, M., Askari, G., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021). The effect of curcumin in improving lipid profile in patients with cardiovascular risk factors: A systematic review of clinical trials. Advances in Experimental Medicine and Biology, 1291, 165-177."}, {"Citation": "Rainone, F. (2005). Milk thistle. American Family Physician, 72(7), 1285-1288."}, {"Citation": "Ramezannezhad, P., Nouri, A., & Heidarian, E. (2019). Silymarin mitigates diclofenac-induced liver toxicity through inhibition of inflammation and oxidative stress in male rats. Journal of Herbmed Pharmacology, 8(3), 231-237."}, {"Citation": "Salmer\u00f3n-Manzano, E., Garrido-Cardenas, J. A., & Manzano-Agugliaro, F. (2020). Worldwide research trends on medicinal plants. International Journal of Environmental Research and Public Health, 17(10), 3376."}, {"Citation": "Schuppan, D., & Afdhal, N. H. (2008). Liver cirrhosis. The Lancet, 371(9615), 838-851."}, {"Citation": "Seriner, R., Da\u011fl\u0131o\u011flu, K., Co\u015fkun, G., & Bilgin, R. (2022). Examination of the effect of curcumin in experimental liver damage created by diethylnitrosamine in swiss albino mice to superoxide dismutase and catalase activities and glutathione, malondialdehyde, and advanced oxidation protein products levels. Biotechnology and Applied Biochemistry, 69(3), 1217-1225."}, {"Citation": "Sharifi, S., Bagherniya, M., Khoram, Z., Ebrahimi Varzaneh, A., Atkin, S. L., Jamialahmadi, T., Sahebkar, A., & Askari, G. (2023). Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: A double-blind, randomized, placebo-controlled clinical trial. Phytotherapy Research. https://doi.org/10.1002/ptr.7764"}, {"Citation": "Shi, Z.-Y., Zeng, J.-Z., & Wong, A. S. T. (2019). Chemical structures and pharmacological profiles of ginseng saponins. Molecules, 24(13), 2443."}, {"Citation": "So, S.-H., Lee, J. W., Kim, Y.-S., Hyun, S. H., & Han, C.-K. (2018). Red ginseng monograph. Journal of Ginseng Research, 42(4), 549-561."}, {"Citation": "Soleimani, V., Delghandi, P. S., Moallem, S. A., & Karimi, G. (2019). Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. Phytotherapy Research, 33(6), 1627-1638."}, {"Citation": "Solhi, H., Ghahremani, R., Kazemifar, A. M., & Yazdi, Z. H. (2014). Silymarin in treatment of non-alcoholic steatohepatitis: A randomized clinical trial. Caspian Journal of Internal Medicine, 5(1), 9-12."}, {"Citation": "Soltani, S., Boozari, M., Cicero, A. F. G., Jamialahmadi, T., & Sahebkar, A. (2021). Effects of phytochemicals on macrophage cholesterol efflux capacity: Impact on atherosclerosis. Phytotherapy Research, 35(6), 2854-2878."}, {"Citation": "Tabrizi, R., Vakili, S., Akbari, M., Mirhosseini, N., Lankarani, K. B., Rahimi, M., Mobini, M., Jafarnejad, S., Vahedpoor, Z., & Asemi, Z. (2019). The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research, 33(2), 253-262."}, {"Citation": "Talebi, S., Bagherniya, M., Atkin, S. L., Askari, G., Orafai, H. M., & Sahebkar, A. (2020). The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: A clinical review. Lipids in Health and Disease, 19(1), 66."}, {"Citation": "Tao, L., Qu, X., Zhang, Y., Song, Y., & Zhang, S.-X. (2019). Prophylactic therapy of silymarin (milk thistle) on antituberculosis drug-induced liver injury: A meta-analysis of randomized controlled trials. Canadian Journal of Gastroenterology and Hepatology, 2019, 3192351. https://doi.org/10.1155/2019/3192351"}, {"Citation": "Tighe, S. P., Akhtar, D., Iqbal, U., & Ahmed, A. (2020). Chronic liver disease and silymarin: A biochemical and clinical review. Journal of Clinical and Translational Hepatology, 8(4), 454-455."}, {"Citation": "Trinchet, J., Coste, T., Levy, V., Vivet, F., Duchatelle, V., Legendre, C., Gotheil, C., & Beaugrand, M. (1989). Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients. Gastroent\u00e9rologie Clinique et Biologique, 13(2), 120-124."}, {"Citation": "Tsai, J. H., Liu, J. Y., Wu, T. T., Ho, P. C., Huang, C. Y., Shyu, J. C., Hsieh, Y. S., Tsai, C. C., & Liu, Y. C. (2008). Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats. Journal of Viral Hepatitis, 15(7), 508-514."}, {"Citation": "Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014). Liver cirrhosis. The Lancet, 383(9930), 1749-1761."}, {"Citation": "Vargas-Mendoza, N., Madrigal-Santill\u00e1n, E., Morales-Gonz\u00e1lez, \u00c1., Esquivel-Soto, J., Esquivel-Chirino, C., Gonz\u00e1lez-Rubio, G. G.-L., Gayosso-de-Lucio, J. A., & Morales-Gonz\u00e1lez, J. A. (2014). Hepatoprotective effect of silymarin. World Journal of Hepatology, 6(3), 144-149."}, {"Citation": "Velussi, M., Cernigoi, A., Viezzoli, L., Dapas, F., Caffau, C., & Zilli, M. (1993). Silymarin reduces hyperinsulinemia, malondialdehyde levels, and daily insulin need in cirrhotic diabetic patients. Current Therapeutic Research, 53(5), 533-545."}, {"Citation": "Velussi, M., Cernigoi, A. M., Dapas, F., Caffau, C., & Zilli, M. (1997). Long-term (23 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. Journal of Hepatology, 26(4), 871-879."}, {"Citation": "Wu, C., Qiu, Y.-B., Sun, X.-Q., Chen, D., Wu, Y.-X., & Pang, Q.-F. (2019). Effects of curcumin on liver fibrosis induced by cholestasis in mice. Zhongguo Ying Yong Sheng Li Xue Za Zhi=Zhongguo Yingyong Shenglixue Zazhi=Chinese Journal of Applied Physiology, 35(5), 468-472."}, {"Citation": "Yoshiji, H., Nagoshi, S., Akahane, T., Asaoka, Y., Ueno, Y., Ogawa, K., Kawaguchi, T., Kurosaki, M., Sakaida, I., Shimizu, M., Taniai, M., Terai, S., Nishikawa, H., Hiasa, Y., Hidaka, H., Miwa, H., Chayama, K., Enomoto, N., Shimosegawa, T., \u2026 Koike, K. (2021). Evidence-based clinical practice guidelines for liver cirrhosis 2020. Journal of Gastroenterology, 56(7), 593-619."}, {"Citation": "Zahedipour, F., Hosseini, S., Henney, N., Barreto, G., & Sahebkar, A. (2022). Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases. Neural Regeneration Research, 17(8), 1675-1684."}, {"Citation": "Zhou, W.-C., Zhang, Q.-B., & Qiao, L. (2014). Pathogenesis of liver cirrhosis. World Journal of Gastroenterology, 20(23), 7312-7324."}, {"Citation": "Zhu, S. Y., Jiang, N., Yang, J., Tu, J., Zhou, Y., Xiao, X., & Dong, Y. (2018). Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice. Biomedicine & Pharmacotherapy, 100, 191-197."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "3", "Day": "11"}, {"Year": "2022", "Month": "10", "Day": "27"}, {"Year": "2023", "Month": "3", "Day": "19"}, {"Year": "2023", "Month": "7", "Day": "5", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "23", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "23", "Hour": "3", "Minute": "44"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37218361", "10.1002/ptr.7816"]}}], "PubmedBookArticle": []}